Activation of intrahepatic CD44- and CD69-expressing CD8 T cells has been reported to promote NASH and HCC through interactions with hepatocytes and by inducing liver damage in mice fed a CD-HFD (46). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.